At the fusion of fintech and medical research, Mural is modernizing the patient-trial connectRead more...
Taking a behind-the-scenes look at the $115 million post-money financing
FourSquare Labs announced on their blog on Tuesday that it finally closed on its second round of financing. Many have been anticipating this, so this week we are going to take a look at the deal terms of this latest round.
FourSquare Labs, Inc. is headquartered in New York, New York. The company provides online mobile social networking services through a Location Based Service application that provides information and entertainment services that are accessible with mobile devices.
The company recently announced on their blog that they have closed on a Series B round of financing in the amount of $20 MM. Participating in this new round were Union Square Ventures, Andreesen Horowitz, and O'Reilly AlphaTech Ventures. The deal terms for this latest round were:
- Filing Date: 06/29/2010
- Liquidation Preference for the Current Round:Pari Passu
- Round of Financing: Series B
- Multiple of the Liquidation Preference: 1x
- Type of Preferred Stock: Conventional Convertible
- Anti-Dilution Protection: Weighted Average
- Redemption at Investor's Option: No
- Pay-to-Play Provisions: No
- Cumulative Dividends: No
- Price Per Share: $13.413
- Amount Raised in Current Round: $20 MM
Utilizing data contained in VC Experts Valuation & Deal Term database, most of which come from the company's regulatory filing, we calculated the post-money valuation of the Series B round to be $115,000,058.20.
For a closer look at the numbers driving this valuation, sign up for our monthly subscription package.
VC Experts is the trusted resource for thousands of entrepreneurs, fund managers and industry related service providers. Visit www.vcexperts.com today to get the data & analytics that can help save your company thousands of dollars and research hours.
Support VatorNews by Donating
Read more from our "Trends and news" series
Those tools include voice and screen-based activations that reduce manual work for physiciansRead more...
The firm invests in early-stage startups combating loss of biodiversityRead more...